Your browser doesn't support javascript.
loading
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
Saeidi, Soma; Kim, Su-Jung; Guillen-Quispe, Yanymee N; Jagadeesh, Achanta Sri Venkata; Han, Hyeong-Jun; Kim, Seung Hyeon; Zhong, Xiancai; Piao, Juan-Yu; Kim, Seong-Jin; Jeong, Joon; Shin, Yun Jin; Cha, Yoon Jin; Lee, Han-Byoel; Han, Wonshik; Min, Sang-Hyun; Tian, Wang; Kitamura, Hiroshi; Surh, Young-Joon.
Afiliación
  • Saeidi S; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Kim SJ; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.
  • Guillen-Quispe YN; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Jagadeesh ASV; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Han HJ; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.
  • Kim SH; Cancer Research Institute, Seoul National University, Seoul, South Korea.
  • Zhong X; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Piao JY; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Kim SJ; Cancer Research Institute, Seoul National University, Seoul, South Korea.
  • Jeong J; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Shin YJ; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Cha YJ; GILO Institute, Seoul, South Korea.
  • Lee HB; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Han W; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Min SH; Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Tian W; Cancer Research Institute, Seoul National University, Seoul, South Korea.
  • Kitamura H; Department of Surgery, Seoul National University Hospital, Seoul, South Korea.
  • Surh YJ; Cancer Research Institute, Seoul National University, Seoul, South Korea.
FASEB J ; 36(1): e22068, 2022 01.
Article en En | MEDLINE | ID: mdl-34918396
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Peptidilprolil Isomerasa de Interacción con NIMA / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: FASEB J Asunto de la revista: BIOLOGIA / FISIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Peptidilprolil Isomerasa de Interacción con NIMA / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: FASEB J Asunto de la revista: BIOLOGIA / FISIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos